Our observations suggest that the alterations of PON1 activity by anthocyanin observed in hypercholesterolemic HDL reflect a shift to an improvement of cholesterol efflux capacity of HDL and may provide a link between anthocyanin and cardioprotective effects.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2013) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: